OrbiMed Capital GP VII LLC

10% OwnerPassage BIO, Inc. (PASG) · full profile →Form 4 · filed Sep 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$147K
Net Open-Market Flow
-$147K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2024Sell(S)26K$0.73$19K7.8M
Sep 17, 2024Sell(S)111K$0.73$81K7.9M
Sep 16, 2024Sell(S)63K$0.74$47K8.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-24-000763) within minutes of acceptance. Every field above traces to the original document. Verify it directly: